Key result
Co-occurring depression and lipid metabolic dysfunction linked to ~71% greater risk of incident cardiometabolic multimorbidity.
Why the study?
The joint effects and dynamic co-trajectories of depression and lipid metabolic dysfunction on cardiometabolic multimorbidity risk across diverse ageing populations remained poorly understood.
Does the combination of depression and lipid metabolic dysfunction increase the risk of incident cardiometabolic multimorbidity in middle-aged and older adults?
Cohort
Yes
Does the combination of depression and lipid metabolic dysfunction increase the risk of incident cardiometabolic multimorbidity in middle-aged and older adults?
Hazard Ratio: 1.71 (95% CI 1.45–2.01)
Depression and lipid metabolic dysfunction independently and jointly increase the risk of incident cardiometabolic multimorbidity, highlighting the potential value of integrating mental health and metabolic screening in primary prevention.
Suggests holistic depression-lipid screening in prevention; extends observational CMM data but leaves causal effects and interventions open.
Background Cardiometabolic multimorbidity (CMM) imposes a growing public health burden on middle-aged and older adults. Depression and lipid metabolic dysfunction are modifiable risk factors for CMM, yet their joint effects and dynamic co-trajectories on CMM risk across diverse ageing populations remain poorly understood. Methods This prospective multicohort study used individual-level data from the China Health and Retirement Longitudinal Study (CHARLS) and the English Longitudinal Study of Ageing (ELSA). Two analytical risk sets were defined to support static and dynamic analyses. Metabolic status was assessed using the atherogenic index of plasma (AIP) and remnant cholesterol (RC); depressive symptoms were measured by the Centre for Epidemiologic Studies Depression Scale (CES-D). Cox proportional hazards regression, counterfactual population attributable fractions (PAF), interaction analyses, and trajectory analyses were applied to examine associations between depression, metabolic status, and incident CMM. Multiple sensitivity analyses confirmed robustness. Results Depression and metabolic dysfunction each independently increased CMM risk, and their co-occurrence conferred the highest risk (AIP, fully adjusted: CHARLS HR = 1.71, 95% CI 1.45–2.01; ELSA HR = 1.55, 95% CI 1.26–1.89), with consistent findings for RC. In the dynamic analysis, persistent co-exposure to elevated metabolic burden and depression was associated with the greatest CMM risk in CHARLS (HR = 2.78, 95% CI 1.73–4.45), with a consistent directional pattern in ELSA. Conclusions Depression and lipid metabolic dysfunction independently and jointly increase incident CMM risk across two nationally representative ageing cohorts. Integrating mental health screening and metabolic assessment into CMM primary prevention may offer meaningful reductions in disease burden across diverse ageing populations.
No takes yet. Share an insight, caveat, or question.
Zeng et al. (2026) conducted a cohort in Cardiometabolic multimorbidity. Depression and lipid metabolic dysfunction vs. Absence of depression and lipid metabolic dysfunction was evaluated on Incident cardiometabolic multimorbidity (HR 1.71, 95% CI 1.45-2.01). Co-occurrence of depression and lipid metabolic dysfunction increased the risk of incident cardiometabolic multimorbidity in the CHARLS (HR 1.71; 95% CI 1.45-2.01) and ELSA cohorts.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: